Friday, September 08, 2017 10:56:48 AM
If the market doesn't think the next surgical competitor to the DaVinci monopoly, thoughtfully designed with surgeon's input, being actively tested at a major center, aiming for FDA submission within 1 year, and that can be had for 10 cents a share, isn't worth a reasonable bet, then I have to take it that there is some glaring problem with this story.
McNally NEVER counted on this comatose state that NO ONE can explain. We would be better off with him doing the biggest song and dance, snake oil salesman's pitch that this world has ever seen, not crickets as usual.
The next show he's going to has hundreds of companies presenting; did you see the list? He's grasping at straws now.
IMO, Titan will be sold off at a price where he can cover his own ass; that's about it.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM